Jamaica vs Slovakia: Access to anti-retroviral drugs, female
Jamaica
62.0%
in 2024
Slovakia
63.0%
in 2018
Jamaica rank
99th
Slovakia rank
96th
Access to anti-retroviral drugs, female over time
- Jamaica
- Slovakia
How they compare
Slovakia currently reports 63.0% against 62.0% in Jamaica, a difference of 1.0%.
Across all 19 years both countries report, Slovakia has been ahead every year.
Jamaica ranks 99th and Slovakia ranks 96th of 141 countries.
Slovakia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jamaica | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.8% | 26.3% | 20.5% | Slovakia |
| 2010s | 37.3% | 55.4% | 18.1% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Jamaica or Slovakia?
- Slovakia, at 63.0% against 62.0% in Jamaica as of 2018.
- What is the difference in access to anti-retroviral drugs, female between Jamaica and Slovakia?
- 1.0%, with Slovakia ahead.
- How many years of comparable data are there for Jamaica and Slovakia?
- 19 years are reported by both, from 2000 to 2018.
- How do Jamaica and Slovakia rank globally for access to anti-retroviral drugs, female?
- Jamaica ranks 99th and Slovakia ranks 96th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.